NASDAQ:ELAN - Elanco Animal Health Stock Price, News & Analysis

$29.81
+0.45 (+1.53 %)
(As of 08/19/2019 04:00 PM ET)
Add
Today's Range
$29.38
Now: $29.81
$29.95
50-Day Range
$28.76
MA: $32.76
$34.76
52-Week Range
$28.00
Now: $29.81
$37.61
Volume1.42 million shs
Average Volume5.75 million shs
Market Capitalization$10.90 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Elanco Animal Health Inc

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:ELAN
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$10.90 billion
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive ELAN News and Ratings via Email

Sign-up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.


Elanco Animal Health (NASDAQ:ELAN) Frequently Asked Questions

What is Elanco Animal Health's stock symbol?

Elanco Animal Health trades on the NASDAQ under the ticker symbol "ELAN."

How were Elanco Animal Health's earnings last quarter?

Elanco Animal Health (NASDAQ:ELAN) posted its quarterly earnings data on Tuesday, August, 13th. The company reported $0.28 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.26 by $0.02. The company had revenue of $781.60 million for the quarter, compared to analysts' expectations of $781.49 million. The business's quarterly revenue was up 1.5% on a year-over-year basis. View Elanco Animal Health's Earnings History.

When is Elanco Animal Health's next earnings date?

Elanco Animal Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Elanco Animal Health.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health issued an update on its FY19 earnings guidance on Tuesday, August, 13th. The company provided EPS guidance of $1.04-1.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.09. The company issued revenue guidance of $3.08-3.12 billion, compared to the consensus revenue estimate of $3.11 billion.

What price target have analysts set for ELAN?

14 Wall Street analysts have issued 1-year target prices for Elanco Animal Health's stock. Their predictions range from $29.71 to $38.00. On average, they expect Elanco Animal Health's stock price to reach $33.3327 in the next twelve months. This suggests a possible upside of 11.8% from the stock's current price. View Analyst Price Targets for Elanco Animal Health.

What is the consensus analysts' recommendation for Elanco Animal Health?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last year. There are currently 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Elanco Animal Health.

Has Elanco Animal Health been receiving favorable news coverage?

News headlines about ELAN stock have been trending negative recently, InfoTrie Sentiment reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Elanco Animal Health earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Elanco Animal Health.

What other stocks do shareholders of Elanco Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Elanco Animal Health investors own include Home Depot (HD), Thermo Fisher Scientific (TMO), NVIDIA (NVDA), Johnson & Johnson (JNJ), Amgen (AMGN), Cisco Systems (CSCO), Alibaba Group (BABA), Honeywell International (HON), Mcdonald's (MCD) and Verizon Communications (VZ).

When did Elanco Animal Health IPO?

(ELAN) raised $1.4 billion in an initial public offering (IPO) on Thursday, September 20th 2018. The company issued 62,900,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by many different of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (11.58%), Vanguard Group Inc. (8.73%), Primecap Management Co. CA (8.40%), BlackRock Inc. (5.60%), Morgan Stanley (3.56%) and Amundi Pioneer Asset Management Inc. (3.11%). Company insiders that own Elanco Animal Health stock include Jeffrey N Simmons, John P Bilbrey, Lawrence Erik Kurzius, R David Hoover and Ramiro Martin Cabral. View Institutional Ownership Trends for Elanco Animal Health.

Which institutional investors are selling Elanco Animal Health stock?

ELAN stock was sold by a variety of institutional investors in the last quarter, including Laurion Capital Management LP, Janus Henderson Group PLC, Janus Henderson Group PLC, Waddell & Reed Financial Inc., Canada Pension Plan Investment Board, Bank of America Corp DE, TimesSquare Capital Management LLC and Korea Investment CORP. View Insider Buying and Selling for Elanco Animal Health.

Which institutional investors are buying Elanco Animal Health stock?

ELAN stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Bessemer Group Inc., Price T Rowe Associates Inc. MD, Vanguard Group Inc., JPMorgan Chase & Co., Morgan Stanley, UBS Asset Management Americas Inc. and Nuveen Asset Management LLC. Company insiders that have bought Elanco Animal Health stock in the last two years include Jeffrey N Simmons, John P Bilbrey, Lawrence Erik Kurzius, R David Hoover and Ramiro Martin Cabral. View Insider Buying and Selling for Elanco Animal Health.

How do I buy shares of Elanco Animal Health?

Shares of ELAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Elanco Animal Health's stock price today?

One share of ELAN stock can currently be purchased for approximately $29.81.

How big of a company is Elanco Animal Health?

Elanco Animal Health has a market capitalization of $10.90 billion. View Additional Information About Elanco Animal Health.


MarketBeat Community Rating for Elanco Animal Health (NASDAQ ELAN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about Elanco Animal Health and other stocks. Vote "Outperform" if you believe ELAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel